Averto Medical is led by a distinguished Board of Directors with deep expertise in biotechnology, medical technology, finance, and healthcare innovation. Their collective leadership has shaped industry-defining companies, guided successful IPOs and acquisitions, and brought life-changing medical solutions to market. With a shared vision, they are steering Averto Medical towards transforming colorectal surgery worldwide.
A seasoned leader in biotechnology and medical innovation, Dr. Ken Song brings a proven track record of building and scaling companies. Most recently, he led RayzeBio from launch to a $350M+ IPO and a $4.1B acquisition by BMS. With expertise spanning biopharmaceuticals, diagnostics, and venture capital, Dr. Song has co-founded and led multiple high-impact healthcare companies, guiding them through strategic growth and major acquisitions.
As the Founder of Cormorant Asset Management, Bihua Chen is a leading investor in biotechnology, medical technology, and life sciences. With decades of experience in investment strategy, portfolio management, and capital growth, she has been instrumental in funding and supporting breakthrough healthcare innovations. Her expertise ensures that Averto Medical remains financially strong and strategically positioned for long-term success.
A financial leader in the medtech sector, Dan Puckett played a pivotal role as CFO of Shockwave Medical, guiding the company from early-stage development to a multi-billion-dollar enterprise. With executive experience at Counsyl, Ariosa Diagnostics (acquired by Roche), and Affymetrix, he brings unmatched financial acumen and operational expertise, ensuring Averto Medical’s continued growth and financial sustainability.
A pioneering medical device innovator, Dr. Kenton Fong has developed life-changing technologies used by hundreds of thousands of patients. With 50+ patents to his name and leadership roles at Curaseal and Spiracur (acquired by 3M), Dr. Fong’s expertise in surgical innovation, clinical research, and patient-centered solutions drives Averto Medical’s mission to revolutionize colorectal surgery.
With decades of strategic leadership, medical expertise, and financial vision, our Board of Directors is dedicated to advancing surgical care, improving patient outcomes, and driving innovation in colorectal surgery.
